Hepatitis B virus core antigen epitopes presented by HLA‐A2 single‐chain trimers induce functional epitope‐specific CD8+ T‐cell responses in HLA‐A2·1/Kb transgenic mice
Open Access
- 18 January 2007
- journal article
- Published by Wiley in Immunology
- Vol. 121 (1) , 105-112
Abstract
Summary: The potency of CD8+ cytotoxic T lymphocyte (CTL) responses toward core antigen has been shown to affect the outcomes of hepatitis B virus (HBV) infection. Since single‐chain trimers (SCT) composed of peptide epitope β2‐microglobulin (β2m) and major histocompatiblity complex (MHC) class I heavy chain covalently linked together in a single molecule have been shown to stimulate efficient CTL responses, we investigated the properties of human leucocyte antigen (HLA)‐A2 SCTs encoding the HBV core antigen (HBcAg) epitopes C18−27 and C107−115. Transfection of NIH‐3T3 cells with pcDNA3.0‐SCT‐C18−27 and SCT‐C107−115 leads to stable presentation of HBcAg epitopes at the cell surface. HLA‐A2.1/Kb transgenic mice vaccinated with the SCT constructs, either as a DNA vaccine alone or followed by a boost with recombinant vaccinia virus, were shown to generate HBcAg‐specific CTL responses by enzyme‐linked immunospot assay (ELISPOT) and in vitro interferon‐γ release experiments. HBcAg‐specific CTLs from vaccinated HLA‐A2.1/Kb transgenic mice were able to inhibit HBV surface and e antigen expression as indicated by HepG2.2.15 cells. Our data indicate that a DNA vaccine encoding a human HLA‐A2 SCT with HBV epitopes can lead to stable, enhanced HBV core antigen presentation, and may be useful for the control of HBV infection in HLA‐A2‐positive HBV carriers.Keywords
This publication has 29 references indexed in Scilit:
- Synergistic DNA–MVA prime-boost vaccination regimes for malaria and tuberculosisVaccine, 2006
- Optimizing cancer immunotherapy trials: Back to basicsEuropean Journal of Immunology, 2006
- Long‐term persistence of hepatitis B surface antigenand antibody induced by DNA‐mediated immunization results in liver and kidney lesions in miceEuropean Journal of Immunology, 2006
- Anti-HBV immune responses in rhesus macaques elicited by electroporation mediated DNA vaccinationVaccine, 2006
- Inhibition of the hepatitis B virus replication in vitro by an oligodeoxynucleotide containing cytidine-guanosine motifsImmunology Letters, 2006
- Testing of CpG-Optimized Protein and DNA Vaccines against the Hepatitis B Virus in Chimpanzees for Immunogenicity and Protection from ChallengeIntervirology, 2006
- Recognition of HLA-A2-restricted mammaglobin-A-derived epitopesBreast Cancer Research and Treatment, 2004
- Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceInternational Journal of Cancer, 2004
- Comparison of the immune response to a self antigen after DNA immunisation of HLA*A201/H-2Kb and HHD transgenic miceVaccine, 2004
- Quantitative and functional analysis of core‐specific T‐helper cell and CTL activities in acute and chronic hepatitis BLiver International, 1998